  Prostate cancer is the most diagnosed form of cancer in Canadian men, and is
the third leading cause of cancer death. Despite these statistics, prognosis is
relatively good with a sufficiently early diagnosis, making fast and reliable
prostate cancer detection crucial. As imaging-based prostate cancer screening,
such as magnetic resonance imaging (MRI), requires an experienced medical
professional to extensively review the data and perform a diagnosis,
radiomics-driven methods help streamline the process and has the potential to
significantly improve diagnostic accuracy and efficiency, and thus improving
patient survival rates. These radiomics-driven methods currently rely on
hand-crafted sets of quantitative imaging-based features, which are selected
manually and can limit their ability to fully characterize unique prostate
cancer tumour phenotype. In this study, we propose a novel \textit{discovery
radiomics} framework for generating custom radiomic sequences tailored for
prostate cancer detection. Discovery radiomics aims to uncover abstract
imaging-based features that capture highly unique tumour traits and
characteristics beyond what can be captured using predefined feature models. In
this paper, we discover new custom radiomic sequencers for generating new
prostate radiomic sequences using multi-parametric MRI data. We evaluated the
performance of the discovered radiomic sequencer against a state-of-the-art
hand-crafted radiomic sequencer for computer-aided prostate cancer detection
with a feedforward neural network using real clinical prostate multi-parametric
MRI data. Results for the discovered radiomic sequencer demonstrate good
performance in prostate cancer detection and clinical decision support relative
to the hand-crafted radiomic sequencer. The use of discovery radiomics shows
potential for more efficient and reliable automatic prostate cancer detection.
